Familial hypercholesterolaemia trials in Austria

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia

  Where

  Vienna

  Age

  Up to 17 years

  People

  8 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2024-514595-41-00 · EU 2024-514595-41-00
• Phase 3Taking people
  Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  Where

  Vienna

  Age

  2 years to 11 years

  People

  9 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597006
• Phase 4Taking people
  Early TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation

  Where

  Feldkirch, Graz, Klagenfurt Am Woerthersee

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Medical University Of Graz

  See details and how to join2026-525917-29-00 · EU 2026-525917-29-00
• Phase 3Taking people
  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Where

  Salzburg, Vienna

  Age

  6 years to 11 years

  People

  60 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597019